Cargando…
In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy
We report the selection in a 15-year-old boy of a multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing Aeromonas salmonicida after medicinal leech therapy that required an antibiotic prophylaxis based on piperacillin/tazobactam and cotrimoxazole. Whole genome sequencing of the strain...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709350/ https://www.ncbi.nlm.nih.gov/pubmed/29204282 http://dx.doi.org/10.1016/j.nmni.2017.10.005 |
_version_ | 1783282756133847040 |
---|---|
author | Ruppé, E. Cherkaoui, A. Wagner, N. La Scala, G.C. Beaulieu, J.-Y. Girard, M. Frey, J. Lazarevic, V. Schrenzel, J. |
author_facet | Ruppé, E. Cherkaoui, A. Wagner, N. La Scala, G.C. Beaulieu, J.-Y. Girard, M. Frey, J. Lazarevic, V. Schrenzel, J. |
author_sort | Ruppé, E. |
collection | PubMed |
description | We report the selection in a 15-year-old boy of a multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing Aeromonas salmonicida after medicinal leech therapy that required an antibiotic prophylaxis based on piperacillin/tazobactam and cotrimoxazole. Whole genome sequencing of the strain indeed revealed 13 antibiotic resistance genes, including the ESBL CTX-M-3 and the unusual β-lactamase SCO-1. |
format | Online Article Text |
id | pubmed-5709350 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-57093502017-12-04 In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy Ruppé, E. Cherkaoui, A. Wagner, N. La Scala, G.C. Beaulieu, J.-Y. Girard, M. Frey, J. Lazarevic, V. Schrenzel, J. New Microbes New Infect New Resistant Microbes in Human We report the selection in a 15-year-old boy of a multidrug-resistant, extended-spectrum β-lactamase (ESBL)-producing Aeromonas salmonicida after medicinal leech therapy that required an antibiotic prophylaxis based on piperacillin/tazobactam and cotrimoxazole. Whole genome sequencing of the strain indeed revealed 13 antibiotic resistance genes, including the ESBL CTX-M-3 and the unusual β-lactamase SCO-1. Elsevier 2017-10-10 /pmc/articles/PMC5709350/ /pubmed/29204282 http://dx.doi.org/10.1016/j.nmni.2017.10.005 Text en © 2017 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | New Resistant Microbes in Human Ruppé, E. Cherkaoui, A. Wagner, N. La Scala, G.C. Beaulieu, J.-Y. Girard, M. Frey, J. Lazarevic, V. Schrenzel, J. In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy |
title | In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy |
title_full | In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy |
title_fullStr | In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy |
title_full_unstemmed | In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy |
title_short | In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy |
title_sort | in vivo selection of a multidrug-resistant aeromonas salmonicida during medicinal leech therapy |
topic | New Resistant Microbes in Human |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709350/ https://www.ncbi.nlm.nih.gov/pubmed/29204282 http://dx.doi.org/10.1016/j.nmni.2017.10.005 |
work_keys_str_mv | AT ruppee invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy AT cherkaouia invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy AT wagnern invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy AT lascalagc invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy AT beaulieujy invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy AT girardm invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy AT freyj invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy AT lazarevicv invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy AT schrenzelj invivoselectionofamultidrugresistantaeromonassalmonicidaduringmedicinalleechtherapy |